Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 806 results for "Biotech Food"

Biotech stock explodes 80% after the FDA approves a key drug
Business Insider Australia

Biotech stock explodes 73% after the FDA approves the first dr...

(Investing.com) Sarepta Therapeutics shares spiked by as much as 86% in trading on Monday after the US Food and Drug Administration said it approved a key drug. The FDA green-lighted Exondys 51 (eteplirsen), the first approveddrug to treat ... Yahoo! Finance UK and Ireland, 1 week ago
Biotech stock explodes 80% after the FDA approves a key drug Business Insider Australia, 1 week ago
[x]  

62 images for Biotech Food

PharmaVOICE, 1 week ago
European Cleaning Journal, 5 days ago
AgroPages.com, 20 hours ago
New Zealand Herald, 3 days ago
CNBC, 1 week ago
Yahoo! Singapore, 1 week ago
Minyanville, 1 week ago
EuroInvestor, 1 week ago
EuroInvestor, 1 week ago
Motley Fool, 5 days ago
PharmaVOICE

FDA Takes Back Special Protocol Assessment for Active Biotech's Laquinimod

Active Biotech Update On Laquinimod Development: The U.S, Food And Drug Administration Rescinds The Special Protocol Assessment For Laquinimod LUND, Sweden, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Active Biotech (Nasdaq Stockholm: ACTI) provided an ...
 BioSpace1 week ago Active Biotech announces US FDA revokes Special Protocol Assessment for laquinimod  PharmaBiz5 days ago Active Biotech update on laquinimod Development: The U.S, Food and Drug administration rescinds the Special Protocol Assessment for laquinimod  SPi World News1 week ago
[x]  
Monthly Prescribing Reference

FDA Clears Ustekinumab (Stelara) for Crohn's Disease

The US Food and Drug Administration (FDA) has approved ustekinumab ( Stelara , Janssen Biotech, Inc) for the treatment of moderately to severely active Crohn's disease in patients aged 18 years or older. Specifically, the interleukin-12/23 ...
 Dermatology Online Journal6 hours ago Janssen's Stelara approved for Crohn's disease  Chain Drug Review8 hours ago FDA Approves Stelara® for Treatment of Adults with Moderately to Severely Active Crohn's Disease  American Pharmaceutical Review5 hours ago Stelara Approved to Treat Crohn's Disease  Monthly Prescribing Reference5 hours ago
Investor's Business Daily

Puma Races Ahead On Breast Cancer Treatment Drug

Puma Biotechnology ( PBYI ) stock rocketed to an eight-month high Thursday after the U.S. Food and Drug Administration on Tuesday approved its new application for neratinib, a breast cancer treatment drug. An estimated 36,000 patients in the U.S.
 Investor's Business Daily4 days ago Why Puma Biotechnology Inc Roared Higher Today  FOXBusiness.com6 days ago Puma Biotech Announces FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer  BioSpace6 days ago
Monthly Prescribing Reference

ArticleJanssen files BLA for US approval of sirukumab for rheumatoid arthritis24-09-2016

Janssen Biotech says it has submitted a Biologics License Application (BLA) to the US Food and
 Pharma Letter2 days ago BLA Submitted for Investigational RA Drug  Monthly Prescribing Reference6 hours ago Janssen Biotech files US regulatory application for Sirukumab in rheumatoid arthritis  Pharmaceutical Business Review17 hours ago GlaxoSmithKline Files US Regulatory Application for Sirukumab in Rheumatoid Arthritis  Nasdaq3 days ago
[x]  
BayStreet.ca

Puma Biotechnology: Sarepta Isn't the Only Biotech Getting a Boost From the FDA

at 09:51 AM EDT Sarepta Therapeutics ( SRPT ) isn't the only company that's getting a U.S. Food and Drug Administration-related boost this week. Today, shares of Puma Biotechnology ( PBYI ) have surged more than 10% after the company said that the ...
 Minyanville6 days ago Biotech ETF IBB Could Get A Boost From A Potential Gilead Merger Or Acquisitions  Seeking Alpha4 days ago Lipocine's Shares Surge as Company's Oral Testosterone Replacement Therapy Successful in Mid-Stage Study  BayStreet.ca11 hours ago
[x]  
New Scientist

Monsanto Strikes Deal To Use CRISPR Gene-Editing Technology In Food

Biotech andagrochemical big boy Monsanto has acquired a license to use CRISPR genome editing technology from Harvard and MIT's (Massachusetts Institute of Technology) Broad Institute, where the technique was developed. The deal is a non-exclusive ...
 IFLScience12 hours ago Monsanto cuts deal to use CRISPR to engineer food  New Scientist3 days ago
Mail.com

FDA approves lower-cost alternative to biotech drug Humira

The Food and Drug Administration cleared a near-copy of the drug, dubbed Amjevita, developed by Amgen Inc. Regulators approved the drug for more than a half-dozen conditions listed on the original drug's label, including severe psoriasis and Crohn's ...
 Mail.com3 days ago The world's best-selling drug is in line for cheaper competition — eventually  StatNews.com3 days ago New Crohn's Disease Drug Approved by FDA  24/7 Wall St15 hours ago Replacing the drug research contest  LifeHealthPro3 days ago
[x]  

Singh Biotech Receives FDA Orphan Drug Designation For Its Novel Single Domain Antibody For Treatment Of Pancreatic Cancer

TAMPA, FLORIDA (PRWEB) SEPTEMBER 19, 2016 Singh Biotechnology today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ...
 BioSpace3 days ago Singh Biotechnology Receives FDA Orphan Drug Designation for its Novel Single Domain Antibody for Treatment of Pancreatic Cancer  PharmiWeb3 days ago
Motley Fool

3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions

Image source: . Roughly 90% of drugs in clinical trials never make it to the Food and Drug Administration for review, so it's not surprising that a green light can be a market-moving event, especially when it's granted to drugs targeting ...
 Motley Fool5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less